_:n751ef51a512e4a609012b9388c42a4b0xb2
<http://schema.org/item>
<https://theperfectenemy.com/atriva-therapeutics-announces-topline-results-from-the-proof-of-concept-poc-phase-2a-respire-study-zapnometinib-in-patients-hospitalized-with-covid-19/>